Casdin Capital

Casdin Capital Overview

Investor Type Hedge Fund
Status Active
Professionals 6
Professionals
Investments 77
Portfolio 39
Exits 25
Exits

Casdin Capital General Information

Description

Founded in 2012, Casdin Capital is a sector-oriented hedge fund manager based in New York, New York. The firm primarily invests in companies operating in the biotechnology, healthcare, life science, information technology and industrial sectors.

Contact Information

Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
  • 1350 Avenue of the Americas
  • Suite 2405
  • New York, NY 10019
  • United States
+1 (212) 000-0000

Casdin Capital Investments (77)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
insitro 26-May-2020 Early Stage VC 00000 Other Healthcare Technology Systems Startup
0000000 01-May-2020 0000 000.00 Drug Discovery Generating Revenue/Not Profitable
00000 000000000000 07-Apr-2020 00000 00000 0000 Biotechnology Generating Revenue
0000 000000000000 31-Mar-2020 00000 00000 0000 Drug Discovery Startup
00000000 25-Mar-2020 00000 00000 00000 Biotechnology Startup
000000 04-Mar-2020 00 000000000 0000 Drug Discovery Generating Revenue
00000000 02-Mar-2020 0000 0000 Biotechnology Generating Revenue
0000 000000 21-Feb-2020 00000 00000 0000 Application Software Generating Revenue
Verana Health 05-Feb-2020 Later Stage VC 00000 Other Healthcare Services Generating Revenue
Vineti 05-Feb-2020 Later Stage VC 0000 Decision/Risk Analysis Generating Revenue
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Casdin Capital Exits (24)

To view Casdin Capital‘s complete exit history, request access »
Company Name Exit Date Exit Type Exit Size
Oric Pharmaceuticals 24-Apr-2020 IPO 00000
0000000000 0000000 13-Feb-2020 000 00000
00000 0000000 0000 29-Jan-2020 000 00000
0000000 0000000000 18-Jul-2019 000 0000
00000000 000000000 27-Jun-2019 000 00000
0000000 07-Feb-2019 000 00000
000000000 00000000 28-Sep-2018 000 00000
0000000000000 0000 19-Jul-2018 000 0000
Neon Therapeutics 27-Jun-2018 IPO 00000
Magenta Therapeutics 21-Jun-2018 IPO 00000

Casdin Capital Team (19)

Name Title Deals Funds Boards Office
Evans Apeadu Chief Financial Officer New York, NY
Lawrence Canzoneri Chief Financial Officer New York, NY
Alexandria Fisk Chief Operating Officer New York, NY
Eli Casdin Founder, Chief Investment Officer & Managing Director 00 0 0 New York, NY
Kelly Galvin Director, IR & Business Development New York, NY

6 Former Team Members